angiotensin ii has been researched along with ginsenoside re in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cui, X; Hong, L; Jin, HH; Li, X; Liu, LP; Liu, X; Zhang, B; Zhang, QG | 1 |
Byun, JK; Jeong, JH; Kim, DJ; Kim, HC; Ko, SK; Lee, Y; Lei, XG; Nabeshima, T; Nah, SY; Nguyen, BT; Sharma, N; Shin, EJ | 1 |
2 other study(ies) available for angiotensin ii and ginsenoside re
Article | Year |
---|---|
Ginsenoside Re prevents angiotensin II-induced gap-junction remodeling by activation of PPARĪ³ in isolated beating rat atria.
Topics: Angiotensin II; Anilides; Animals; Blotting, Western; Connexin 43; Connexins; Dose-Response Relationship, Drug; Down-Regulation; Female; Gap Junction alpha-5 Protein; Gap Junctions; Ginsenosides; Heart Atria; Male; Matrix Metalloproteinase 2; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2017 |
Ginsenoside Re attenuates memory impairments in aged Klotho deficient mice via interactive modulations of angiotensin II AT1 receptor, Nrf2 and GPx-1 gene.
Topics: Angiotensin II; Animals; Antioxidants; Ginsenosides; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Klotho Proteins; Losartan; Memory Disorders; Mice; Mice, Knockout; NF-E2-Related Factor 2; Reactive Oxygen Species; Receptor, Angiotensin, Type 1 | 2022 |